Korean Idiopathic Pulmonary Fibrosis Registry

Sponsor
Seoul National University Hospital
Study ID
NCT04160715
Status
Recruiting
Apply to this trial

Conditions

  • Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex
ALL
Age
30 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.

Key Dates

First listed
Nov 13, 2019
Start date
Jan 31, 2016
Status verified
Nov 2019
Primary completion
Jan 31, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
3,000 participants (estimated)

Primary Outcome Measure

survival of IPF [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

Related Studies